ADORA2A and neurodegenerative disease: The exciting work performed on A2AR mediated neurodegeneration performed by several groups (Gomes et al., 2011; Santiago et al., 2014; Laurent et al., 2016; Ferreira et al., 2017a) opens up a major role for A2AR antagonists in neurodegenerative disease involving alpha-synucleins.